nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ABCC1—Dactinomycin—sarcoma	0.165	0.195	CbGbCtD
Abiraterone—ABCC1—Mitoxantrone—sarcoma	0.148	0.174	CbGbCtD
Abiraterone—ABCC1—Epirubicin—sarcoma	0.12	0.141	CbGbCtD
Abiraterone—ABCC1—Vincristine—sarcoma	0.102	0.12	CbGbCtD
Abiraterone—ABCC1—Etoposide—sarcoma	0.0933	0.11	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—sarcoma	0.0637	0.075	CbGbCtD
Abiraterone—CYP3A4—Thiotepa—sarcoma	0.0498	0.0587	CbGbCtD
Abiraterone—CYP2C8—Etoposide—sarcoma	0.0333	0.0392	CbGbCtD
Abiraterone—CYP3A4—Mitoxantrone—sarcoma	0.0214	0.0252	CbGbCtD
Abiraterone—CYP3A4—Vincristine—sarcoma	0.0147	0.0174	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—sarcoma	0.0145	0.0171	CbGbCtD
Abiraterone—CYP3A4—Etoposide—sarcoma	0.0135	0.0159	CbGbCtD
Abiraterone—CYP3A4—Doxorubicin—sarcoma	0.0092	0.0108	CbGbCtD
Abiraterone—SULT2A1—hematopoietic system—sarcoma	0.00164	0.132	CbGeAlD
Abiraterone—Contusion—Mitoxantrone—sarcoma	0.00156	0.0112	CcSEcCtD
Abiraterone—Fluid retention—Thiotepa—sarcoma	0.0015	0.0108	CcSEcCtD
Abiraterone—Hepatotoxicity—Etoposide—sarcoma	0.00147	0.0105	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Thiotepa—sarcoma	0.00132	0.00946	CcSEcCtD
Abiraterone—Chest discomfort—Etoposide—sarcoma	0.00128	0.0092	CcSEcCtD
Abiraterone—Lymphopenia—Epirubicin—sarcoma	0.00124	0.00892	CcSEcCtD
Abiraterone—Hypernatraemia—Epirubicin—sarcoma	0.00121	0.00868	CcSEcCtD
Abiraterone—Cardiac failure—Thiotepa—sarcoma	0.00117	0.00843	CcSEcCtD
Abiraterone—Lymphopenia—Doxorubicin—sarcoma	0.00115	0.00825	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Etoposide—sarcoma	0.00113	0.00814	CcSEcCtD
Abiraterone—Hypernatraemia—Doxorubicin—sarcoma	0.00112	0.00803	CcSEcCtD
Abiraterone—Hypophosphataemia—Epirubicin—sarcoma	0.00109	0.00786	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.00103	0.00741	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.00102	0.00736	CcSEcCtD
Abiraterone—Cardiac failure—Mitoxantrone—sarcoma	0.00101	0.00728	CcSEcCtD
Abiraterone—Hypophosphataemia—Doxorubicin—sarcoma	0.00101	0.00727	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Thiotepa—sarcoma	0.00101	0.00726	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Etoposide—sarcoma	0.000946	0.0068	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Vincristine—sarcoma	0.000914	0.00657	CcSEcCtD
Abiraterone—Hypokalaemia—Mitoxantrone—sarcoma	0.0009	0.00647	CcSEcCtD
Abiraterone—SULT2A1—testis—sarcoma	0.000898	0.0723	CbGeAlD
Abiraterone—Hyperglycaemia—Thiotepa—sarcoma	0.000893	0.00642	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.00089	0.0064	CcSEcCtD
Abiraterone—Pneumonia—Thiotepa—sarcoma	0.000888	0.00638	CcSEcCtD
Abiraterone—Infestation—Thiotepa—sarcoma	0.000882	0.00634	CcSEcCtD
Abiraterone—Infestation NOS—Thiotepa—sarcoma	0.000882	0.00634	CcSEcCtD
Abiraterone—Pneumonia—Dactinomycin—sarcoma	0.000881	0.00633	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.000872	0.00627	CcSEcCtD
Abiraterone—SULT2A1—liver—sarcoma	0.000849	0.0683	CbGeAlD
Abiraterone—Cardiac failure—Etoposide—sarcoma	0.000843	0.00606	CcSEcCtD
Abiraterone—Haematuria—Thiotepa—sarcoma	0.000841	0.00605	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.000794	0.00571	CcSEcCtD
Abiraterone—Pneumonia—Vincristine—sarcoma	0.000787	0.00566	CcSEcCtD
Abiraterone—Urinary tract disorder—Thiotepa—sarcoma	0.000782	0.00562	CcSEcCtD
Abiraterone—Connective tissue disorder—Thiotepa—sarcoma	0.000778	0.00559	CcSEcCtD
Abiraterone—Urethral disorder—Thiotepa—sarcoma	0.000777	0.00558	CcSEcCtD
Abiraterone—Acute coronary syndrome—Vincristine—sarcoma	0.000771	0.00554	CcSEcCtD
Abiraterone—Hyperglycaemia—Mitoxantrone—sarcoma	0.000771	0.00554	CcSEcCtD
Abiraterone—Myocardial infarction—Vincristine—sarcoma	0.000767	0.00551	CcSEcCtD
Abiraterone—Pneumonia—Mitoxantrone—sarcoma	0.000766	0.00551	CcSEcCtD
Abiraterone—Acute coronary syndrome—Mitoxantrone—sarcoma	0.000751	0.0054	CcSEcCtD
Abiraterone—Myocardial infarction—Mitoxantrone—sarcoma	0.000747	0.00537	CcSEcCtD
Abiraterone—Urinary tract infection—Mitoxantrone—sarcoma	0.000741	0.00532	CcSEcCtD
Abiraterone—Cardiac disorder—Thiotepa—sarcoma	0.000735	0.00528	CcSEcCtD
Abiraterone—Haematuria—Mitoxantrone—sarcoma	0.000727	0.00522	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Etoposide—sarcoma	0.000725	0.00521	CcSEcCtD
Abiraterone—ALB—mammary gland—sarcoma	0.000721	0.058	CbGeAlD
Abiraterone—Angiopathy—Thiotepa—sarcoma	0.000719	0.00517	CcSEcCtD
Abiraterone—Mediastinal disorder—Thiotepa—sarcoma	0.000714	0.00513	CcSEcCtD
Abiraterone—Arrhythmia—Thiotepa—sarcoma	0.000708	0.00509	CcSEcCtD
Abiraterone—Mental disorder—Thiotepa—sarcoma	0.000694	0.00499	CcSEcCtD
Abiraterone—Urinary tract disorder—Vincristine—sarcoma	0.000694	0.00499	CcSEcCtD
Abiraterone—Connective tissue disorder—Vincristine—sarcoma	0.00069	0.00496	CcSEcCtD
Abiraterone—Urethral disorder—Vincristine—sarcoma	0.000689	0.00495	CcSEcCtD
Abiraterone—CYP17A1—connective tissue—sarcoma	0.000687	0.0553	CbGeAlD
Abiraterone—Nocturia—Epirubicin—sarcoma	0.000685	0.00492	CcSEcCtD
Abiraterone—Cardiac disorder—Vincristine—sarcoma	0.000652	0.00469	CcSEcCtD
Abiraterone—SULT2A1—lymph node—sarcoma	0.000651	0.0524	CbGeAlD
Abiraterone—Pneumonia—Etoposide—sarcoma	0.000638	0.00458	CcSEcCtD
Abiraterone—Anaemia—Thiotepa—sarcoma	0.000637	0.00458	CcSEcCtD
Abiraterone—Angiopathy—Vincristine—sarcoma	0.000637	0.00458	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Epirubicin—sarcoma	0.000635	0.00457	CcSEcCtD
Abiraterone—Infestation NOS—Etoposide—sarcoma	0.000634	0.00456	CcSEcCtD
Abiraterone—Infestation—Etoposide—sarcoma	0.000634	0.00456	CcSEcCtD
Abiraterone—Nocturia—Doxorubicin—sarcoma	0.000634	0.00455	CcSEcCtD
Abiraterone—Mediastinal disorder—Vincristine—sarcoma	0.000633	0.00455	CcSEcCtD
Abiraterone—Anaemia—Dactinomycin—sarcoma	0.000633	0.00455	CcSEcCtD
Abiraterone—Acute coronary syndrome—Etoposide—sarcoma	0.000625	0.00449	CcSEcCtD
Abiraterone—Myocardial infarction—Etoposide—sarcoma	0.000621	0.00447	CcSEcCtD
Abiraterone—Mental disorder—Vincristine—sarcoma	0.000615	0.00442	CcSEcCtD
Abiraterone—Arrhythmia—Mitoxantrone—sarcoma	0.000611	0.00439	CcSEcCtD
Abiraterone—Fluid retention—Epirubicin—sarcoma	0.000603	0.00433	CcSEcCtD
Abiraterone—Cough—Thiotepa—sarcoma	0.000602	0.00432	CcSEcCtD
Abiraterone—Hypertension—Thiotepa—sarcoma	0.000595	0.00428	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Doxorubicin—sarcoma	0.000588	0.00422	CcSEcCtD
Abiraterone—Myalgia—Thiotepa—sarcoma	0.000587	0.00422	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000583	0.00419	CcSEcCtD
Abiraterone—Myalgia—Dactinomycin—sarcoma	0.000583	0.00419	CcSEcCtD
Abiraterone—Discomfort—Dactinomycin—sarcoma	0.000576	0.00414	CcSEcCtD
Abiraterone—Anaemia—Vincristine—sarcoma	0.000565	0.00406	CcSEcCtD
Abiraterone—Urinary tract disorder—Etoposide—sarcoma	0.000562	0.00404	CcSEcCtD
Abiraterone—Infection—Thiotepa—sarcoma	0.000559	0.00402	CcSEcCtD
Abiraterone—Oedema—Dactinomycin—sarcoma	0.000559	0.00401	CcSEcCtD
Abiraterone—Fluid retention—Doxorubicin—sarcoma	0.000558	0.00401	CcSEcCtD
Abiraterone—Urethral disorder—Etoposide—sarcoma	0.000558	0.00401	CcSEcCtD
Abiraterone—Infection—Dactinomycin—sarcoma	0.000555	0.00399	CcSEcCtD
Abiraterone—Anaemia—Mitoxantrone—sarcoma	0.00055	0.00396	CcSEcCtD
Abiraterone—Skin disorder—Thiotepa—sarcoma	0.000547	0.00393	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.00053	0.00381	CcSEcCtD
Abiraterone—Cardiac disorder—Etoposide—sarcoma	0.000528	0.0038	CcSEcCtD
Abiraterone—Hypertension—Vincristine—sarcoma	0.000528	0.00379	CcSEcCtD
Abiraterone—Myalgia—Vincristine—sarcoma	0.000521	0.00374	CcSEcCtD
Abiraterone—Cough—Mitoxantrone—sarcoma	0.00052	0.00373	CcSEcCtD
Abiraterone—Angiopathy—Etoposide—sarcoma	0.000516	0.00371	CcSEcCtD
Abiraterone—Hypertension—Mitoxantrone—sarcoma	0.000514	0.0037	CcSEcCtD
Abiraterone—Mediastinal disorder—Etoposide—sarcoma	0.000513	0.00369	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000513	0.00369	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000509	0.00366	CcSEcCtD
Abiraterone—Chest pain—Mitoxantrone—sarcoma	0.000507	0.00364	CcSEcCtD
Abiraterone—Myalgia—Mitoxantrone—sarcoma	0.000507	0.00364	CcSEcCtD
Abiraterone—CYP2C8—mammary gland—sarcoma	0.000507	0.0408	CbGeAlD
Abiraterone—ORM1—hematopoietic system—sarcoma	0.000501	0.0403	CbGeAlD
Abiraterone—Discomfort—Mitoxantrone—sarcoma	0.000501	0.0036	CcSEcCtD
Abiraterone—Oedema—Vincristine—sarcoma	0.000499	0.00359	CcSEcCtD
Abiraterone—Infection—Vincristine—sarcoma	0.000496	0.00356	CcSEcCtD
Abiraterone—Dyspepsia—Thiotepa—sarcoma	0.000495	0.00356	CcSEcCtD
Abiraterone—Hot flush—Epirubicin—sarcoma	0.000493	0.00354	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.00049	0.00353	CcSEcCtD
Abiraterone—Menopausal symptoms—Epirubicin—sarcoma	0.000489	0.00351	CcSEcCtD
Abiraterone—Oedema—Mitoxantrone—sarcoma	0.000486	0.00349	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Thiotepa—sarcoma	0.000486	0.00349	CcSEcCtD
Abiraterone—Fatigue—Thiotepa—sarcoma	0.000485	0.00349	CcSEcCtD
Abiraterone—Infection—Mitoxantrone—sarcoma	0.000483	0.00347	CcSEcCtD
Abiraterone—Fatigue—Dactinomycin—sarcoma	0.000482	0.00346	CcSEcCtD
Abiraterone—Constipation—Thiotepa—sarcoma	0.000481	0.00346	CcSEcCtD
Abiraterone—Cardiac failure—Epirubicin—sarcoma	0.000472	0.0034	CcSEcCtD
Abiraterone—Skin disorder—Mitoxantrone—sarcoma	0.000472	0.00339	CcSEcCtD
Abiraterone—Anaemia—Etoposide—sarcoma	0.000458	0.00329	CcSEcCtD
Abiraterone—Hot flush—Doxorubicin—sarcoma	0.000456	0.00328	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Vincristine—sarcoma	0.000455	0.00327	CcSEcCtD
Abiraterone—Menopausal symptoms—Doxorubicin—sarcoma	0.000452	0.00325	CcSEcCtD
Abiraterone—Insomnia—Vincristine—sarcoma	0.000451	0.00324	CcSEcCtD
Abiraterone—Body temperature increased—Thiotepa—sarcoma	0.000445	0.0032	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000443	0.00318	CcSEcCtD
Abiraterone—Body temperature increased—Dactinomycin—sarcoma	0.000442	0.00317	CcSEcCtD
Abiraterone—Cardiac failure—Doxorubicin—sarcoma	0.000437	0.00314	CcSEcCtD
Abiraterone—Dyspnoea—Mitoxantrone—sarcoma	0.000433	0.00311	CcSEcCtD
Abiraterone—Cough—Etoposide—sarcoma	0.000432	0.00311	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Vincristine—sarcoma	0.000431	0.0031	CcSEcCtD
Abiraterone—Fatigue—Vincristine—sarcoma	0.00043	0.00309	CcSEcCtD
Abiraterone—Dyspepsia—Mitoxantrone—sarcoma	0.000428	0.00307	CcSEcCtD
Abiraterone—Hypertension—Etoposide—sarcoma	0.000428	0.00307	CcSEcCtD
Abiraterone—Constipation—Vincristine—sarcoma	0.000427	0.00307	CcSEcCtD
Abiraterone—ABCC1—myometrium—sarcoma	0.000422	0.034	CbGeAlD
Abiraterone—Chest pain—Etoposide—sarcoma	0.000422	0.00303	CcSEcCtD
Abiraterone—Hypokalaemia—Epirubicin—sarcoma	0.00042	0.00302	CcSEcCtD
Abiraterone—Fatigue—Mitoxantrone—sarcoma	0.000419	0.00301	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000419	0.00301	CcSEcCtD
Abiraterone—Discomfort—Etoposide—sarcoma	0.000417	0.00299	CcSEcCtD
Abiraterone—Constipation—Mitoxantrone—sarcoma	0.000416	0.00299	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000415	0.00298	CcSEcCtD
Abiraterone—Nasopharyngitis—Epirubicin—sarcoma	0.000412	0.00296	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000407	0.00292	CcSEcCtD
Abiraterone—Asthenia—Thiotepa—sarcoma	0.000404	0.0029	CcSEcCtD
Abiraterone—Infection—Etoposide—sarcoma	0.000402	0.00289	CcSEcCtD
Abiraterone—Asthenia—Dactinomycin—sarcoma	0.000401	0.00288	CcSEcCtD
Abiraterone—Body temperature increased—Vincristine—sarcoma	0.000395	0.00284	CcSEcCtD
Abiraterone—Skin disorder—Etoposide—sarcoma	0.000393	0.00282	CcSEcCtD
Abiraterone—CYP17A1—testis—sarcoma	0.000391	0.0315	CbGeAlD
Abiraterone—Hypokalaemia—Doxorubicin—sarcoma	0.000388	0.00279	CcSEcCtD
Abiraterone—Diarrhoea—Thiotepa—sarcoma	0.000385	0.00277	CcSEcCtD
Abiraterone—Body temperature increased—Mitoxantrone—sarcoma	0.000384	0.00276	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000384	0.00276	CcSEcCtD
Abiraterone—Diarrhoea—Dactinomycin—sarcoma	0.000382	0.00275	CcSEcCtD
Abiraterone—ABCC1—seminal vesicle—sarcoma	0.000382	0.0307	CbGeAlD
Abiraterone—Nasopharyngitis—Doxorubicin—sarcoma	0.000381	0.00274	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000376	0.0027	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Epirubicin—sarcoma	0.00037	0.00266	CcSEcCtD
Abiraterone—CYP17A1—liver—sarcoma	0.00037	0.0297	CbGeAlD
Abiraterone—Pollakiuria—Epirubicin—sarcoma	0.000368	0.00265	CcSEcCtD
Abiraterone—Dyspnoea—Etoposide—sarcoma	0.00036	0.00259	CcSEcCtD
Abiraterone—Hyperglycaemia—Epirubicin—sarcoma	0.000359	0.00258	CcSEcCtD
Abiraterone—Asthenia—Vincristine—sarcoma	0.000358	0.00257	CcSEcCtD
Abiraterone—Vomiting—Thiotepa—sarcoma	0.000358	0.00257	CcSEcCtD
Abiraterone—Pneumonia—Epirubicin—sarcoma	0.000357	0.00257	CcSEcCtD
Abiraterone—Infestation NOS—Epirubicin—sarcoma	0.000355	0.00255	CcSEcCtD
Abiraterone—Infestation—Epirubicin—sarcoma	0.000355	0.00255	CcSEcCtD
Abiraterone—Vomiting—Dactinomycin—sarcoma	0.000355	0.00255	CcSEcCtD
Abiraterone—Rash—Thiotepa—sarcoma	0.000355	0.00255	CcSEcCtD
Abiraterone—Dermatitis—Thiotepa—sarcoma	0.000355	0.00255	CcSEcCtD
Abiraterone—Rash—Dactinomycin—sarcoma	0.000352	0.00253	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Etoposide—sarcoma	0.000349	0.00251	CcSEcCtD
Abiraterone—Asthenia—Mitoxantrone—sarcoma	0.000349	0.00251	CcSEcCtD
Abiraterone—Fatigue—Etoposide—sarcoma	0.000349	0.00251	CcSEcCtD
Abiraterone—Constipation—Etoposide—sarcoma	0.000346	0.00248	CcSEcCtD
Abiraterone—Urinary tract infection—Epirubicin—sarcoma	0.000345	0.00248	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000343	0.00246	CcSEcCtD
Abiraterone—Diarrhoea—Vincristine—sarcoma	0.000341	0.00245	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—sarcoma	0.000341	0.00245	CcSEcCtD
Abiraterone—Haematuria—Epirubicin—sarcoma	0.000339	0.00243	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—sarcoma	0.000333	0.00239	CcSEcCtD
Abiraterone—Diarrhoea—Mitoxantrone—sarcoma	0.000333	0.00239	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—sarcoma	0.000331	0.00238	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—sarcoma	0.000329	0.00236	CcSEcCtD
Abiraterone—Infestation—Doxorubicin—sarcoma	0.000329	0.00236	CcSEcCtD
Abiraterone—ORM1—bone marrow—sarcoma	0.000321	0.0258	CbGeAlD
Abiraterone—Body temperature increased—Etoposide—sarcoma	0.00032	0.0023	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—sarcoma	0.00032	0.0023	CcSEcCtD
Abiraterone—Vomiting—Vincristine—sarcoma	0.000317	0.00228	CcSEcCtD
Abiraterone—Urinary tract disorder—Epirubicin—sarcoma	0.000315	0.00226	CcSEcCtD
Abiraterone—Rash—Vincristine—sarcoma	0.000315	0.00226	CcSEcCtD
Abiraterone—Dermatitis—Vincristine—sarcoma	0.000314	0.00226	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—sarcoma	0.000313	0.00225	CcSEcCtD
Abiraterone—Connective tissue disorder—Epirubicin—sarcoma	0.000313	0.00225	CcSEcCtD
Abiraterone—Urethral disorder—Epirubicin—sarcoma	0.000313	0.00225	CcSEcCtD
Abiraterone—Vomiting—Mitoxantrone—sarcoma	0.000309	0.00222	CcSEcCtD
Abiraterone—CYP2C8—hematopoietic system—sarcoma	0.000309	0.0248	CbGeAlD
Abiraterone—Rash—Mitoxantrone—sarcoma	0.000306	0.0022	CcSEcCtD
Abiraterone—Dermatitis—Mitoxantrone—sarcoma	0.000306	0.0022	CcSEcCtD
Abiraterone—Cardiac disorder—Epirubicin—sarcoma	0.000296	0.00213	CcSEcCtD
Abiraterone—Urinary tract disorder—Doxorubicin—sarcoma	0.000291	0.00209	CcSEcCtD
Abiraterone—Asthenia—Etoposide—sarcoma	0.00029	0.00208	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—sarcoma	0.00029	0.00208	CcSEcCtD
Abiraterone—Angiopathy—Epirubicin—sarcoma	0.000289	0.00208	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—sarcoma	0.000289	0.00208	CcSEcCtD
Abiraterone—Mediastinal disorder—Epirubicin—sarcoma	0.000287	0.00207	CcSEcCtD
Abiraterone—Arrhythmia—Epirubicin—sarcoma	0.000285	0.00205	CcSEcCtD
Abiraterone—CYP17A1—lymph node—sarcoma	0.000283	0.0228	CbGeAlD
Abiraterone—Mental disorder—Epirubicin—sarcoma	0.000279	0.00201	CcSEcCtD
Abiraterone—Diarrhoea—Etoposide—sarcoma	0.000277	0.00199	CcSEcCtD
Abiraterone—ABCC1—cardiac atrium—sarcoma	0.000275	0.0222	CbGeAlD
Abiraterone—ABCC1—uterus—sarcoma	0.000274	0.022	CbGeAlD
Abiraterone—Cardiac disorder—Doxorubicin—sarcoma	0.000274	0.00197	CcSEcCtD
Abiraterone—Angiopathy—Doxorubicin—sarcoma	0.000268	0.00192	CcSEcCtD
Abiraterone—Mediastinal disorder—Doxorubicin—sarcoma	0.000266	0.00191	CcSEcCtD
Abiraterone—Arrhythmia—Doxorubicin—sarcoma	0.000264	0.00189	CcSEcCtD
Abiraterone—ORM1—liver—sarcoma	0.00026	0.0209	CbGeAlD
Abiraterone—Mental disorder—Doxorubicin—sarcoma	0.000259	0.00186	CcSEcCtD
Abiraterone—Vomiting—Etoposide—sarcoma	0.000257	0.00185	CcSEcCtD
Abiraterone—Anaemia—Epirubicin—sarcoma	0.000257	0.00184	CcSEcCtD
Abiraterone—Rash—Etoposide—sarcoma	0.000255	0.00183	CcSEcCtD
Abiraterone—Dermatitis—Etoposide—sarcoma	0.000255	0.00183	CcSEcCtD
Abiraterone—Cough—Epirubicin—sarcoma	0.000242	0.00174	CcSEcCtD
Abiraterone—ALB—testis—sarcoma	0.000241	0.0194	CbGeAlD
Abiraterone—ABCC1—tendon—sarcoma	0.00024	0.0193	CbGeAlD
Abiraterone—Hypertension—Epirubicin—sarcoma	0.00024	0.00172	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—sarcoma	0.000237	0.00171	CcSEcCtD
Abiraterone—Myalgia—Epirubicin—sarcoma	0.000236	0.0017	CcSEcCtD
Abiraterone—Chest pain—Epirubicin—sarcoma	0.000236	0.0017	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000235	0.00169	CcSEcCtD
Abiraterone—Discomfort—Epirubicin—sarcoma	0.000234	0.00168	CcSEcCtD
Abiraterone—ALB—liver—sarcoma	0.000228	0.0183	CbGeAlD
Abiraterone—Oedema—Epirubicin—sarcoma	0.000227	0.00163	CcSEcCtD
Abiraterone—Infection—Epirubicin—sarcoma	0.000225	0.00162	CcSEcCtD
Abiraterone—Cough—Doxorubicin—sarcoma	0.000224	0.00161	CcSEcCtD
Abiraterone—Hypertension—Doxorubicin—sarcoma	0.000222	0.00159	CcSEcCtD
Abiraterone—Skin disorder—Epirubicin—sarcoma	0.00022	0.00158	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—sarcoma	0.000219	0.00157	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—sarcoma	0.000219	0.00157	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000217	0.00156	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—sarcoma	0.000216	0.00155	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—sarcoma	0.00021	0.00151	CcSEcCtD
Abiraterone—CYP3A4—hematopoietic system—sarcoma	0.000209	0.0168	CbGeAlD
Abiraterone—Infection—Doxorubicin—sarcoma	0.000208	0.0015	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000206	0.00148	CcSEcCtD
Abiraterone—CYP2D6—hematopoietic system—sarcoma	0.000206	0.0166	CbGeAlD
Abiraterone—Insomnia—Epirubicin—sarcoma	0.000205	0.00147	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—sarcoma	0.000204	0.00146	CcSEcCtD
Abiraterone—Dyspnoea—Epirubicin—sarcoma	0.000202	0.00145	CcSEcCtD
Abiraterone—Dyspepsia—Epirubicin—sarcoma	0.000199	0.00143	CcSEcCtD
Abiraterone—ORM1—lymph node—sarcoma	0.000199	0.016	CbGeAlD
Abiraterone—ABCC1—testis—sarcoma	0.000199	0.016	CbGeAlD
Abiraterone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000196	0.00141	CcSEcCtD
Abiraterone—Fatigue—Epirubicin—sarcoma	0.000195	0.0014	CcSEcCtD
Abiraterone—Constipation—Epirubicin—sarcoma	0.000194	0.00139	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000191	0.00137	CcSEcCtD
Abiraterone—Insomnia—Doxorubicin—sarcoma	0.00019	0.00136	CcSEcCtD
Abiraterone—ABCC1—liver—sarcoma	0.000188	0.0151	CbGeAlD
Abiraterone—Dyspnoea—Doxorubicin—sarcoma	0.000187	0.00134	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—sarcoma	0.000185	0.00133	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000181	0.0013	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—sarcoma	0.000181	0.0013	CcSEcCtD
Abiraterone—Constipation—Doxorubicin—sarcoma	0.000179	0.00129	CcSEcCtD
Abiraterone—Body temperature increased—Epirubicin—sarcoma	0.000179	0.00129	CcSEcCtD
Abiraterone—ALB—lymph node—sarcoma	0.000175	0.014	CbGeAlD
Abiraterone—CYP2C8—testis—sarcoma	0.000169	0.0136	CbGeAlD
Abiraterone—Body temperature increased—Doxorubicin—sarcoma	0.000166	0.00119	CcSEcCtD
Abiraterone—Asthenia—Epirubicin—sarcoma	0.000163	0.00117	CcSEcCtD
Abiraterone—CYP2C8—liver—sarcoma	0.00016	0.0129	CbGeAlD
Abiraterone—Diarrhoea—Epirubicin—sarcoma	0.000155	0.00111	CcSEcCtD
Abiraterone—Asthenia—Doxorubicin—sarcoma	0.00015	0.00108	CcSEcCtD
Abiraterone—Vomiting—Epirubicin—sarcoma	0.000144	0.00104	CcSEcCtD
Abiraterone—ABCC1—lymph node—sarcoma	0.000144	0.0116	CbGeAlD
Abiraterone—Diarrhoea—Doxorubicin—sarcoma	0.000143	0.00103	CcSEcCtD
Abiraterone—Rash—Epirubicin—sarcoma	0.000143	0.00103	CcSEcCtD
Abiraterone—Dermatitis—Epirubicin—sarcoma	0.000143	0.00103	CcSEcCtD
Abiraterone—Vomiting—Doxorubicin—sarcoma	0.000133	0.000958	CcSEcCtD
Abiraterone—Rash—Doxorubicin—sarcoma	0.000132	0.00095	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—sarcoma	0.000132	0.000949	CcSEcCtD
Abiraterone—CYP2D6—testis—sarcoma	0.000113	0.00907	CbGeAlD
Abiraterone—CYP3A4—liver—sarcoma	0.000108	0.00872	CbGeAlD
Abiraterone—CYP2D6—liver—sarcoma	0.000107	0.00858	CbGeAlD
